[go: up one dir, main page]

AU6964898A - Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells - Google Patents

Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells

Info

Publication number
AU6964898A
AU6964898A AU69648/98A AU6964898A AU6964898A AU 6964898 A AU6964898 A AU 6964898A AU 69648/98 A AU69648/98 A AU 69648/98A AU 6964898 A AU6964898 A AU 6964898A AU 6964898 A AU6964898 A AU 6964898A
Authority
AU
Australia
Prior art keywords
cancer
administration
treatment
fas ligand
tumorigenic cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69648/98A
Inventor
Helen M Blau
Andreas Hofmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU6964898A publication Critical patent/AU6964898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU69648/98A 1997-04-11 1998-04-10 Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells Abandoned AU6964898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4188097P 1997-04-11 1997-04-11
US60041880 1997-04-11
PCT/US1998/007235 WO1998046242A1 (en) 1997-04-11 1998-04-10 Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells

Publications (1)

Publication Number Publication Date
AU6964898A true AU6964898A (en) 1998-11-11

Family

ID=21918839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69648/98A Abandoned AU6964898A (en) 1997-04-11 1998-04-10 Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells

Country Status (2)

Country Link
AU (1) AU6964898A (en)
WO (1) WO1998046242A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20121877U1 (en) * 2001-09-27 2003-09-18 LeukoCare GmbH, 85646 Neufarn Module for suppressing leukocyte activity, useful e.g. in association with heart-lung machines, comprises a carrier linked to a ligand specific for the leukocyte receptor

Also Published As

Publication number Publication date
WO1998046242A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
AU1196400A (en) Improved radioactive therapeutic seeds and methods of making the same
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2655599A (en) Endoluminal implant with therapeutic and diagnostic capability
AU6113390A (en) Compounds for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
AU4473596A (en) Methods of human prostate cancer diagnosis
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU2508597A (en) Drug for the treatment of tumours
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
AU5005697A (en) Methods of preventing breast cancer
AU2965199A (en) Medicine mini-chest
AU7058000A (en) 13 human colon and colon cancer associated proteins
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU6006898A (en) Skin preparation
AU7089800A (en) 29 human cancer associated proteins
AU2506499A (en) Cea/nca-based differentiation cancer therapy
AU5429896A (en) Rage tumor rejection antigens
AU1744600A (en) Detection of t cell stimulating tumor antigens
AU6964898A (en) Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells
AU6683998A (en) Aortic cannula
AU5946999A (en) Tumour therapy and imaging
AU1800100A (en) Medicinal preparations
AU2462895A (en) Enhancing the sensitivity of tumor cells to therapies
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer